Chemoprevention of colorectal cancer
AssigneeSofar SPA
InventorsAlexis Grande, Fabrizio Ferrarini, Sandra Parenti
Life of this patent
Estimating the term…
Abstract
In the present invention, a new combination is disclosed comprising (i) 5-aminosalicylic acid (5-ASA) or a derivative thereof, or a pharmacologically acceptable salt thereof, and (ii) a group D vitamin, a derivative thereof, a metabolite or analogue, for use in the prevention and/or treatment of colorectal cancer (CRC). A further aspect of the invention is directed to pharmaceutical compositions comprising said combination together with at least one physiologically acceptable excipient and the use thereof in the prevention and/or in the treatment of the colorectal cancer.
Claims11
1-16. (canceled)
A method of preventing or treating colorectal cancer, comprising administering to a patient a daily dose of a combination comprising:
- (i) a 5-aminosalicylic acid component, wherein the 5-aminosalicylic acid component comprises 5-aminosalicylic acid or a pharmacologically acceptable salt of 5-aminosalicylic acid;
- and
- (ii) a group D vitamin component, wherein the group D vitamin component is selected from the group consisting of vitamin D3, vitamin D2, 25-hydroxy-vitamin D3 and 1-alpha,25 dihydroxy-vitamin D3;
- wherein the combination comprises between 0.5 grams and 5 grams of the 5-aminosalicylic acid component and between 500 international units and 10,000 international units of the group D vitamin component;
- wherein the combination does not include calcium;
- and
- wherein the method prevents or treats colorectal cancer.
Dependencies are inferred from the claim text.